BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9742894)

  • 1. Bladder cancer: state-of-the-art care.
    Droller MJ
    CA Cancer J Clin; 1998; 48(5):269-84. PubMed ID: 9742894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and therapy of bladder cancer].
    Jokisch JF; Ganswindt U; Hentrich M; Stief C; Karl A
    MMW Fortschr Med; 2015 Nov; 157(20):42-5. PubMed ID: 26977514
    [No Abstract]   [Full Text] [Related]  

  • 3. Staging and prognosis of T3b bladder cancer.
    Levy DA; Grossman HB
    Semin Urol Oncol; 1996 May; 14(2):56-61. PubMed ID: 8734732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in assessment and treatment of bladder cancer.
    Hassen W; Droller MJ
    Curr Opin Urol; 2000 Jul; 10(4):291-9. PubMed ID: 10918966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in urothelial carcinoma].
    Vögeli TA; Ackermann R
    Urologe A; 2001 Nov; 40(6):442-6. PubMed ID: 11760346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer.
    Lamm DL
    J Urol; 2000 Sep; 164(3 Pt 1):690-1. PubMed ID: 10953126
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and staging of bladder cancer.
    Sun M; Trinh QD
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):205-18, vii. PubMed ID: 25836929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder.
    Kundra V; Silverman PM
    AJR Am J Roentgenol; 2003 Apr; 180(4):1045-54. PubMed ID: 12646453
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria.
    Segal AJ; Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche PJ; Holder LE; Newhouse JH; Sandler CM; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():765-72. PubMed ID: 11037498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?
    Bruchbacher A; Soria F; Hassler M; Shariat SF; D'Andrea D
    Curr Opin Urol; 2018 Nov; 28(6):584-590. PubMed ID: 30188332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bladder carcinoma--a current review].
    Engeler DS; Schmid HP
    Praxis (Bern 1994); 2003 Jan; 92(4):117-26. PubMed ID: 12632842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and staging of bladder cancer.
    Cummings KB; Barone JG; Ward WS
    Urol Clin North Am; 1992 Aug; 19(3):455-65. PubMed ID: 1636230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of tumor recurrence and progression of superficial bladder carcinoma using an artificial neural network].
    Planz B; Deix T; Caspers HP
    Urologe A; 2007 Sep; 46(9):1138-9. PubMed ID: 17668171
    [No Abstract]   [Full Text] [Related]  

  • 16. Bladder cancer. Current diagnostic methods and treatment options.
    Badalament RA; Schervish EW
    Postgrad Med; 1996 Aug; 100(2):217-9, 223-4, 230. PubMed ID: 8700819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
    Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology diagnosis of bladder carcinoma].
    Rübben H; Otto T
    Urologe A; 2000 Mar; 39(2):178-81. PubMed ID: 10768231
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Contreras-Sanz A; Roberts ME; Seiler R; Black PC
    Int J Urol; 2017 Jan; 24(1):7-15. PubMed ID: 27597124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.